15/05/2012Shortage of NHS prescription drugs putting UK patients at riskThere is a shortage of certain drugs in the UK as medicines are being bought cheaply and sold at higher prices in Europe. UK patients are losing out in the drug shortage The All-Party Pharmacy Group...
15/05/2012Cancer deaths fall to lowest record level for people in their 50sThe number of people dying from cancer in their 50’s has fallen to its lowest record level. Figures from Cancer Research UK show a 40 per cent drop in cancer deaths among 50 to 59 year olds. Now, 185 in...
15/05/2012MRSA breeds in city hospitals and spreads to local hospitals by patient transferThe superbug MRSA spreads from large city hospitals to smaller local hospitals by patient transfer, according to a study published in the journal PNAS. MRSA is a type of bacterial infection that is resistant...
14/05/2012NICE to reverse its decision on prostate cancer drug abirateroneIt has been reported that the National Institute of Health and Clinical Excellence is reconsidering its ban on late-stage prostate cancer drug abiraterone. The outlook for prostate cancer is generally good,...
14/05/2012Five-a-day campaign failing to improve British dietOnly one in five people in the UK eat the recommended five portions of fruit and veg a day, according to a new poll. The YouGov survey of more than 2,000 UK adults, carried out for the World Cancer Research...
14/05/2012Use Waist to Height Ratio to predict your risk of diabetes, not BMIWaist to Height Ratio is a better predictor of heart disease and diabetes risk than body mass index (BMI), according to new research. British scientists analysed a team of 300,000 people, and found that Waist...
11/05/2012Too many workers without financial back-up plan against unemploymentNew research shows that too many people have no financial back-up plan if they should be unable to work. New MetLife research shows that 41 per cent of people have no financial back up plan if illness or a...
11/05/2012Prostate cancer drug cabazitaxel turned down for use on the NHSProstate cancer drug cabazitaxel, marketed as JEVTANA, has been turned down for use on the NHS by the National Institute of Health and Clinical Excellence (NICE). The outlook for prostate cancer is generally...
11/05/2012Botox recommended by NICE for treating chronic migraines on the NHSFinal draft guidelines from the National Institute for Health and Clinical Excellence (NICE) recommend Botox for patients with chronic migraines when other drugs have failed. Botox recommended for...
10/05/2012Lifestyle Cover, a new income protection product from Legal and GeneralActiveQuote is pleased to announce the addition of a new product to its income protection comparison system: Lifestyle Cover from Legal & General. Lifestyle Cover is a 5 star Defaqto rated short-term...